# RNN 1st Gen Model Boston Scientific Corporation Surgical & medical instruments

Stock predictor AI models:
74.47% successful of 47 deals
$ 43.13 Last close price
at 29-oct-2021


Model's trade recommendations 1.40% Return for period

8.96% Annual return

$40.39B Market Cap

β 0.81  


Model (following trade recommendations)


Underlying stock

S&P 500

Return for period 1.40%
52wk return 6.78%
52wk Range
Sortino ratio 2.06
Sharpe ratio 1.15
Norm. RMSE 0.46%
Downside risk 4.13%
Volatility 0.00%
  • STRONG BUY Analysts consensus recommendation

Boston Scientific Corporation transforms lives through innovative medical solutions that improve the health of patients around the world. As a global medical technology leader they advance science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce the cost of healthcare.

Industry sector: Medical

Sector classification: Surgical & medical instruments

Deep Learning based analysis and prediction model for Boston Scientific Corporation (BSX) stock is a 1st Generation Non-linear Autoregresive with exogenous variable(s) (NARX) model based on the Recurrent Neural Network architecture.

Model is in the production pipeline since Sept. 30, 2015.

Market data for BSX model training are being downloaded from the Quandl premium datasets on a daily basis.
Risks related to the novel coronavirus disease 2019 (COVID-19) caused by the virus named “SARS-CoV-2” are accounted for in this model in the form of the historical data coincided with outbreaks and other global events in the past used to train ML prediction model for BSX.

Model is being retrained on a daily basis.

Float 1365M
P/E 22.51
Shares Outstanding 1380M
% Held by Insiders 0.73%
% Held by Institutions 90.98%
EPS (last reported FY) $1.26
EPS (last reported Q) $0.33
EPS, estimated (last reported Q) $0.31
Total revenues $9 B
Net income $0 B